TMED Financials 07/16/2014 16:23:05 Trimedyne, In

TMED Financials 07/16/2014 16:23:05
Trimedyne, Inc.
Period Ending Sep 30, 2013 Sep 30, 2012 Sep 30, 2011 Sep 30, 2010
Total Revenue 5,989 6,080 6,656 6,401
Cost of Revenue 3,621 4,083 4,574 4,197
Gross Profit 2,368 1,997 2,082 2,204
Operating Expenses
Research and Development 407 673 853 1,060
Sales, General and Admin. 2,329 2,494 2,751 2,585
Non-Recurring Items - - - -
Other - - - -
Operating Income (368) (1,170) (1,522) (1,441)
Income From Continuing Operations
Add'l Income/Expense Items 716 357 107 2,135
Earnings Before Interest and Tax 348 (813) (1,415) 694
Interest Expense 2 10 62 40
Earnings Before Tax 346 (823) (1,477) 654
Income Tax 17 13 9 15
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations 329 (836) (1,522) 639
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 329 (836) (1,486) 639
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders 329 (836) (1,486) 639